IntrinsicIntrinsic
← Scroll for more →

Financial Statements — GHST

Balance Sheet

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Cash & Equivalents0.000.000.000.000.000.000.000.000.020.000.000.010.040.000.000.000.000.000.000.00
Accounts Receivable--------0.000.000.010.000.000.010.010.01----------------
Total Current Assets0.000.000.000.000.000.000.010.000.020.010.010.020.040.000.000.000.000.000.000.00
Total Non-current Assets*0.000.000.000.000.000.000.000.000.000.000.000.000.000.040.040.040.150.150.150.15
Total Assets0.000.000.000.000.000.000.010.000.020.010.010.020.040.040.040.040.150.150.160.16
Accounts Payable0.020.010.010.020.030.000.000.010.010.030.020.030.000.000.000.010.000.020.010.02
Total Current Liabilities0.580.570.540.530.490.400.380.320.330.270.240.200.160.110.090.090.090.100.210.29
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.000.00--0.000.000.000.000.00
Total Liabilities*0.580.570.540.530.490.400.380.320.330.270.240.200.160.11--0.090.090.100.210.29
Retained Earnings(14.15)(14.14)(14.11)(14.10)(14.06)(13.97)(13.94)(13.89)(13.88)(13.84)(13.81)(13.43)(13.37)(9.63)(9.60)(9.58)(9.42)(9.38)(9.36)(9.33)
Total Stockholder Equity(0.58)(0.57)(0.54)(0.53)(0.49)(0.40)(0.37)(0.32)(0.31)(0.26)(0.23)(0.18)(0.12)(0.06)--(0.05)0.070.05(0.06)(0.13)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in thousands USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Total Revenue0.000.0010.373.495.114.764.8745.730.790.4315.8523.84----------------
Research & Development----------0.000.00----0.00324.52----10.57------0.0010.57--
Selling, General & Admin44.2718.6023.7335.0593.8036.2948.3151.77359.8328.6072.8078.8425.1721.2919.2448.9235.9423.9531.8658.96
Total Operating Expenses44.2725.5926.3038.5297.2236.2950.5958.4547.1228.60397.3278.84(88.02)22.8820.64163.9235.9423.9531.8658.96
Operating Income------------------------------------44.2848.39
Interest Expense--------------------------0.15----0.000.000.15--
Pretax Income(10.18)(25.59)(15.93)(34.22)--------------------------------
Tax Provision0.000.000.00----------------------------------
Net Income(10.18)(25.59)(15.93)(34.22)(92.88)(31.53)(45.71)(12.72)(46.57)(27.91)(380.70)(56.09)90.87(22.88)(20.64)(163.92)(35.27)(23.95)(33.71)(58.95)
Basic EPS--0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00----
Diluted EPS--0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00----
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(35.54)(25.17)(39.13)(34.39)(27.80)(31.14)(59.58)(45.17)(36.76)(25.79)(58.69)(43.30)(4.97)(21.30)(28.72)(38.32)(49.33)(20.66)(35.95)(57.09)
Investing Cash Flow--------------------------0.00(4.18)------(1.89)(1.64)
Financing Cash Flow35.4325.0838.3433.7230.1831.0557.6629.0454.9924.8152.3211.2439.7521.3832.4738.9949.1720.0232.8653.84
← Scroll for more columns →